Drugs that contain Oxycodone Hydrochloride

1. Drug name - OXAYDO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7510726 ZYLA Methods and compositions for deterring abuse of opioid containing dosage forms Nov, 2023

(1 year, 1 month from now)

US8409616 ZYLA Extended release opioid abuse deterrent compositions and methods of making same Nov, 2023

(1 year, 1 month from now)

US8637540 ZYLA Compositions for deterring abuse of opioid containing dosage forms Nov, 2023

(1 year, 1 month from now)

US7981439 ZYLA Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof Nov, 2023

(1 year, 1 month from now)

US9492443 ZYLA Abuse deterrent compositions and methods of making same May, 2024

(1 year, 7 months from now)

US7201920 ZYLA Methods and compositions for deterring abuse of opioid containing dosage forms Mar, 2025

(2 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
5MG TABLET;ORAL Prescription
7.5MG TABLET;ORAL Prescription

2. Drug name - OXYCONTIN

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9073933 PURDUE PHARMA LP Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
Mar, 2025

(2 years from now)

US10407434 PURDUE PHARMA LP Process for preparing oxycodone compositions
Mar, 2025

(2 years from now)

US9522919 PURDUE PHARMA LP Oxycodone compositions
Mar, 2025

(2 years from now)

US10696684 PURDUE PHARMA LP Process for preparing oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
Mar, 2025

(2 years from now)

CN102127086B PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

CN102887903B PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

CN1960994B PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

CN101812065A PURDUE PHARMA LP A Method For Preparing Oxycodone Hydrochloride Composition With Less Than 25Ppm Of 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

CN102887903A PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

CN102838607A PURDUE PHARMA LP Method For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm Of 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

CN102838607B PURDUE PHARMA LP Preparation Contains Less Than 25 Ppm Of 14-Hydroxide Can Be Oxycodone Method By Hydrochloric Acid
Mar, 2025

(2 years from now)

CN101812065B PURDUE PHARMA LP Contains Less Than 25 Ppm Ppm Of 14-Hydroxymethyl Codeine To Oxycodone Hydrochloride Ketone Can Be Ketone
Mar, 2025

(2 years from now)

CN102127086A PURDUE PHARMA LP Method For Preparing Pancodine Composition Containing Less Than 25 Ppm Of 14-Oxycodone
Mar, 2025

(2 years from now)

CN1960994A PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2305683B1 PURDUE PHARMA LP Pharmaceutical Dosage Form Comprising Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2305683A1 PURDUE PHARMA LP Pharmaceutical Dosage Form Comprising Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2319846A1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2426132A1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Compositions Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP1730151A1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2316837B1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP1730151B2 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP1730151B1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2426132B1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Compositions Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP1730151A4 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2316837A1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2305683B8 PURDUE PHARMA LP Pharmaceutical Dosage Form Comprising Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2319846B1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10369109 PURDUE PHARMA LP Abuse-proofed dosage form Jun, 2023

(8 months from now)

US9675610 PURDUE PHARMA LP Abuse-proofed dosage form Jun, 2023

(8 months from now)

US8309060 PURDUE PHARMA LP Abuse-proofed dosage form Nov, 2023

(1 year, 1 month from now)

US10130591 PURDUE PHARMA LP Abuse-proofed dosage form Nov, 2023

(1 year, 1 month from now)

US10675278 PURDUE PHARMA LP Crush resistant delayed-release dosage forms Nov, 2023

(1 year, 1 month from now)

US9492391 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9492389 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9492392 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US8808741 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9770416 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9775808 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US8894988 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9763933 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9492393 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US8894987 PURDUE PHARMA LP Tamper resistant dosage forms Mar, 2030

(7 years from now)

Treatment: Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate; Management of pain severe enough to require daily, around-the-clock, long term opioid treatment and for which alternative treatment options are inadequate

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
10MG TABLET, EXTENDED RELEASE;ORAL Prescription
15MG TABLET, EXTENDED RELEASE;ORAL Prescription
20MG TABLET, EXTENDED RELEASE;ORAL Prescription
30MG TABLET, EXTENDED RELEASE;ORAL Prescription
40MG TABLET, EXTENDED RELEASE;ORAL Prescription
60MG TABLET, EXTENDED RELEASE;ORAL Prescription
80MG TABLET, EXTENDED RELEASE;ORAL Prescription

3. Drug name - ROXYBOND

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7955619 PROTEGA PHARMS Abuse resistant drugs, method of use and method of making Aug, 2028

(5 years from now)

US10314788 PROTEGA PHARMS Pharmaceutical compositions configured to deter dosage form splitting Aug, 2028

(5 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
5MG TABLET;ORAL Discontinued
15MG TABLET;ORAL Discontinued
30MG TABLET;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.